Coronavirus survivors may carry disease-resistant antibodies in their plasma that could be used to treat others currently battling the disease.
The COVID-19 Convalescent Plasma Pittsburgh Project (C2P3) — a collaboration between AHN and other regional health providers — is seeking Coronavirus survivors to get screened and see if they’re eligible to donate plasma.
If you’ve previously tested positive for Coronavirus and are no longer showing symptoms contact the AHN Convalescent Plasma Donor Team at 412-858-C2P3 or C2P3@ahn.org to learn more about screening and donation.
If you’ve previously tested positive for COVID-19, are no longer showing symptoms and are interested in donating plasma that could help treat other patients fighting the disease, contact the AHN convalescent plasma donor team at 412-858-C2P3 or at C2P3@ahn.org. We will get in touch to evaluate your eligibility and to walk you through the screening process.
It’s a multi-step process. Here’s what you can expect:
Yes. You do not need to be an AHN patient in order to donate to the COVID-19 Convalescent Plasma Pittsburgh Project.
The process is similar to giving blood. Your whole blood is drawn and the plasma is separated. Then, your red blood cells are returned to your body along with a saline solution that helps you generate new plasma to replace the plasma that has been removed.
No, AHN will cover cost implications of plasma donation testing and services for any eligible donor, regardless of insurer or where you typically go for care.